- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Medical University of South Carolina
Headquarters: Charleston, SC, United States
Website: http://www.musc.edu
Year Founded: 1824
Status: Non-biopharma
Biopharma related deals can be found by searching the organization's name in the Deals Module.
BioCentury | Nov 27, 2024
Discovery & Translation
Science Spotlight: Reducing immune rejection of stem cell-derived therapies
BioCentury’s roundup of translational innovation also includes a new target for arrhythmia and four papers with links to newcos
BioCentury | Jul 29, 2023
Discovery & Translation
Turning cancer drivers into cell death drivers; plus LNPs to edit stem cells and more
BioCentury’s roundup of translational innovations
BioCentury | Nov 16, 2022
Deals
Kriya rolls up Redpin, adds neurology to its gene therapy scope
In second M&A deal this year, Patient Square-backed Kriya adds epilepsy, trigeminal neuralgia programs along with platform in ‘nine-digit’ acquisition
BioCentury | Jul 12, 2022
Distillery Therapeutics
Inhibiting USP8 to promote checkpoint inhibitor activity in cancer
BioCentury | May 17, 2022
Finance
Kriya bulking up gene therapy R&D, infrastructure with $270M C round
Since last year’s $100M series B, Kriya has hired a CFO, presidents for oncology, ophthalmology and rare diseases
BioCentury | Jan 27, 2022
Deals
Jan. 26 Quick Takes: Kyverna’s autoimmune cell therapies get lift from $85M series B
Plus clinical hold for Cortexyme’s lead Alzheimer’s therapy; PureTech’s Akili goes public via SPAC; Adlai, Biotime deal; and more
BioCentury | Oct 29, 2021
Discovery & Translation
Omics-based target identification in UK Biobank and COVID-19 cohorts
Plus: technologies from Harvard, Texas A&M, Disney lab and more
BioCentury | Oct 9, 2020
Translation in Brief
Philogen immunocytokine for glioma; plus Nordic's radiotherapy, Beth Israel Deaconness, Molecular Partners and Alpine
BioCentury’s roundup of translational news
BioCentury | May 30, 2020
Translation in Brief
Empirica’s glioblastoma CAR T therapy in mice; plus tumor microbiomes by tumor type, Senhwa and more
BioCentury’s roundup of preclinical news
Items per page:
1 - 10 of 59